Literature DB >> 19815244

Tiglicamides A-C, cyclodepsipeptides from the marine cyanobacterium Lyngbya confervoides.

Susan Matthew1, Valerie J Paul, Hendrik Luesch.   

Abstract

The Floridian marine cyanobacterium Lyngbya confervoides afforded cyclodepsipeptides, termed tiglicamides A-C (1-3), along with their previously reported analogues largamides A-C (4-6), all of which possess an unusual tiglic acid moiety. Their structures were deduced by one- and two-dimensional NMR combined with mass spectrometry and the absolute configurations established by chiral HPLC and Marfey's analysis of the degradation products. Compounds 1-3 moderately inhibited porcine pancreatic elastase in vitro with IC(50) values from 2.14 to 7.28 microM. Compounds 1-6 differ from each other by one amino acid residue within the cyclic core structure, suggesting an unusually relaxed substrate specificity of the nonribosomal peptide synthetase that is the putative biosynthetic enzyme responsible for the corresponding amino acid incorporation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19815244      PMCID: PMC2787822          DOI: 10.1016/j.phytochem.2009.09.010

Source DB:  PubMed          Journal:  Phytochemistry        ISSN: 0031-9422            Impact factor:   4.072


  11 in total

1.  ONO-5046, a novel inhibitor of human neutrophil elastase.

Authors:  K Kawabata; M Suzuki; M Sugitani; K Imaki; M Toda; T Miyamoto
Journal:  Biochem Biophys Res Commun       Date:  1991-06-14       Impact factor: 3.575

2.  Lyngbyastatin 4, a dolastatin 13 analogue with elastase and chymotrypsin inhibitory activity from the marine cyanobacterium Lyngbya confervoides.

Authors:  Susan Matthew; Cliff Ross; James R Rocca; Valerie J Paul; Hendrik Luesch
Journal:  J Nat Prod       Date:  2007-01       Impact factor: 4.050

3.  Largamides A-C, tiglic acid-containing cyclodepsipeptides with elastase-inhibitory activity from the marine cyanobacterium Lyngbya confervoides.

Authors:  Susan Matthew; Valerie J Paul; Hendrik Luesch
Journal:  Planta Med       Date:  2009-02-12       Impact factor: 3.352

4.  Largamides A-H, unusual cyclic peptides from the marine cyanobacterium Oscillatoria sp.

Authors:  Alberto Plaza; Carole A Bewley
Journal:  J Org Chem       Date:  2006-09-01       Impact factor: 4.354

5.  Symplostatin 2: a dolastatin 13 analogue from the marine cyanobacterium Symploca hydnoides.

Authors:  G G Harrigan; H Luesch; W Y Yoshida; R E Moore; D G Nagle; V J Paul
Journal:  J Nat Prod       Date:  1999-04       Impact factor: 4.050

Review 6.  Protease inhibitors in the clinic.

Authors:  Giovanni Abbenante; David P Fairlie
Journal:  Med Chem       Date:  2005-01       Impact factor: 2.745

7.  Phylogenetic and chemical diversity of three chemotypes of bloom-forming lyngbya species (Cyanobacteria: Oscillatoriales) from reefs of southeastern Florida.

Authors:  Koty Sharp; Karen E Arthur; Liangcai Gu; Cliff Ross; Genelle Harrison; Sarath P Gunasekera; Theresa Meickle; Susan Matthew; Hendrik Luesch; Robert W Thacker; David H Sherman; Valerie J Paul
Journal:  Appl Environ Microbiol       Date:  2009-03-06       Impact factor: 4.792

8.  Lyngbyastatins 5-7, potent elastase inhibitors from Floridian marine cyanobacteria, Lyngbya spp.

Authors:  Kanchan Taori; Susan Matthew; James R Rocca; Valerie J Paul; Hendrik Luesch
Journal:  J Nat Prod       Date:  2007-10-03       Impact factor: 4.050

Review 9.  Ribosomal peptide natural products: bridging the ribosomal and nonribosomal worlds.

Authors:  John A McIntosh; Mohamed S Donia; Eric W Schmidt
Journal:  Nat Prod Rep       Date:  2009-04       Impact factor: 13.423

10.  Carriebowmide, a new cyclodepsipeptide from the marine cyanobacterium Lyngbya polychroa.

Authors:  Sarath P Gunasekera; Raphael Ritson-Williams; Valerie J Paul
Journal:  J Nat Prod       Date:  2008-12       Impact factor: 4.050

View more
  13 in total

1.  Cyclic depsipeptides, grassypeptolides D and E and Ibu-epidemethoxylyngbyastatin 3, from a Red Sea Leptolyngbya cyanobacterium.

Authors:  Christopher C Thornburg; Muralidhara Thimmaiah; Lamiaa A Shaala; Andrew M Hau; Jay M Malmo; Jane E Ishmael; Diaa T A Youssef; Kerry L McPhail
Journal:  J Nat Prod       Date:  2011-08-01       Impact factor: 4.050

Review 2.  Therapeutic potential of marine peptides in cervical and ovarian cancers.

Authors:  Salman Ahmed; Haroon Khan; Sajad Fakhri; Michael Aschner; Wai San Cheang
Journal:  Mol Cell Biochem       Date:  2021-12-02       Impact factor: 3.396

3.  Gatorbulin-1, a distinct cyclodepsipeptide chemotype, targets a seventh tubulin pharmacological site.

Authors:  Susan Matthew; Qi-Yin Chen; Ranjala Ratnayake; Charles S Fermaintt; Daniel Lucena-Agell; Francesca Bonato; Andrea E Prota; Seok Ting Lim; Xiaomeng Wang; J Fernando Díaz; April L Risinger; Valerie J Paul; Maria Ángela Oliva; Hendrik Luesch
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-02       Impact factor: 11.205

Review 4.  New peptides isolated from Lyngbya species: a review.

Authors:  Li Liu; Kathleen S Rein
Journal:  Mar Drugs       Date:  2010-06-09       Impact factor: 5.118

5.  Intramolecular modulation of serine protease inhibitor activity in a marine cyanobacterium with antifeedant properties.

Authors:  Susan Matthew; Ranjala Ratnayake; Mikel A Becerro; Raphael Ritson-Williams; Valerie J Paul; Hendrik Luesch
Journal:  Mar Drugs       Date:  2010-06-04       Impact factor: 5.118

Review 6.  New Peptides Isolated from Marine Cyanobacteria, an Overview over the Past Decade.

Authors:  Yue Mi; Jinrong Zhang; Shan He; Xiaojun Yan
Journal:  Mar Drugs       Date:  2017-05-05       Impact factor: 5.118

7.  Indolediketopiperazine Alkaloids from Eurotium cristatum EN-220, an Endophytic Fungus Isolated from the Marine Alga Sargassum thunbergii.

Authors:  Feng-Yu Du; Xin Li; Xiao-Ming Li; Li-Wei Zhu; Bin-Gui Wang
Journal:  Mar Drugs       Date:  2017-01-25       Impact factor: 5.118

Review 8.  Marine cyanobacteria compounds with anticancer properties: a review on the implication of apoptosis.

Authors:  Margarida Costa; João Costa-Rodrigues; Maria Helena Fernandes; Piedade Barros; Vitor Vasconcelos; Rosário Martins
Journal:  Mar Drugs       Date:  2012-09-28       Impact factor: 6.085

Review 9.  Tiny Microbes with a Big Impact: The Role of Cyanobacteria and Their Metabolites in Shaping Our Future.

Authors:  Sophie Mazard; Anahit Penesyan; Martin Ostrowski; Ian T Paulsen; Suhelen Egan
Journal:  Mar Drugs       Date:  2016-05-17       Impact factor: 5.118

Review 10.  Marine Cyanobacteria: A Source of Lead Compounds and their Clinically-Relevant Molecular Targets.

Authors:  Lik Tong Tan; Ma Yadanar Phyo
Journal:  Molecules       Date:  2020-05-08       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.